NCT00394628 - AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2006

Conditions

Glioblastoma Multiforme

Interventions

DRUG

AQ4N

DRUG

Temozolomide

PROCEDURE

Radiotherapy

Trial Locations (5)

RECRUITING

Duke University Medical Center, Durham

RECRUITING

Henry Ford Health Systems, Detroit

RECRUITING

Northwestern University Feinberg School of Medicine, Chicago

RECRUITING

University of California, Los Angeles, Los Angeles

RECRUITING

Baylor Research Institute, Dallas